StockData
Bicycle Therapeutics PLC logo

Bicycle Therapeutics PLC (BCYC) stock

BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3080% below fair value
$3.11−0.09 (-2.81%)

Close on Nov 18, 2026Market cap $217.99MP/E –Yield 0.00%

Bicycle Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Bicycle Therapeutics's revenue for the twelve months ending Sep 30, 2026 was $83.53M, up 194.7% year over year. For fiscal 2025 it was $72.59M, up 105.8% from the year before. The highest annual figure on record is $72.59M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$72.59M+105.8%
FY2024Dec 31, 2024$35.28M+30.8%
FY2023Dec 31, 2023$26.98M+86.5%
FY2022Dec 31, 2022$14.46M+23.6%
FY2021Dec 31, 2021$11.70M+12.6%
FY2020Dec 31, 2020$10.39M-24.7%
FY2019Dec 31, 2019$13.80M+93.4%
FY2018Dec 31, 2018$7.14M+246.4%
FY2017Dec 31, 2017$2.06M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$34.06M+190.2%
Q2 FY2026Jun 30, 2026$629.00K-78.5%
Q1 FY2026Mar 31, 2026$887.00K-91.1%
Q4 FY2025Dec 31, 2025$47.96M+1193.3%
Q3 FY2025Sep 30, 2025$11.73M+338.5%
Q2 FY2025Jun 30, 2025$2.92M-68.8%
Q1 FY2025Mar 31, 2025$9.98M-48.9%
Q4 FY2024Dec 31, 2024$3.71M-30.4%
Q3 FY2024Sep 30, 2024$2.68M-50.0%
Q2 FY2024Jun 30, 2024$9.36M-17.9%
Q1 FY2024Mar 31, 2024$19.53M+298.9%
Q4 FY2023Dec 31, 2023$5.33M+67.4%
Q3 FY2023Sep 30, 2023$5.35M+76.1%
Q2 FY2023Jun 30, 2023$11.40M+160.3%
Q1 FY2023Mar 31, 2023$4.90M+26.8%
Q4 FY2022Dec 31, 2022$3.19M-15.5%
Q3 FY2022Sep 30, 2022$3.04M-29.8%
Q2 FY2022Jun 30, 2022$4.38M+145.3%
Q1 FY2022Mar 31, 2022$3.86M+113.5%
Q4 FY2021Dec 31, 2021$3.77M-2.0%
Q3 FY2021Sep 30, 2021$4.33M+12.8%
Q2 FY2021Jun 30, 2021$1.79M+13.6%
Q1 FY2021Mar 31, 2021$1.81M+60.1%
Q4 FY2020Dec 31, 2020$3.85M-27.1%
Q3 FY2020Sep 30, 2020$3.84M+525.7%
Q2 FY2020Jun 30, 2020$1.57M+3.2%
Q1 FY2020Mar 31, 2020$1.13M-82.3%
Q4 FY2019Dec 31, 2019$5.28M+399.6%
Q3 FY2019Sep 30, 2019$614.00K-61.9%
Q2 FY2019Jun 30, 2019$1.52M-8.4%
Q1 FY2019Mar 31, 2019$6.38M+127.4%
Q4 FY2018Dec 31, 2018$1.06M–
Q3 FY2018Sep 30, 2018$1.61M–
Q2 FY2018Jun 30, 2018$1.66M–
Q1 FY2018Mar 31, 2018$2.81M–

More Bicycle Therapeutics figures

See a number that looks wrong?